This episode accompanies the last module of the course – module 15, which is all about building an evidence-based management capacity in organisations.

There are 3 levels – you as an evidence-based manager; your colleagues who you can influence and guide in evidence based approaches; and the skills, practices and processes in your organisation.

We hear from several experts about ways to build on what you’ve learned, and how others have approached the development of evidence-based practices in their organisations, including the CIPD, the professional HR body, about how it promotes this practice among its membership.

And you’re never alone, there are always others forging a path in evidence-based management who you can reach out to, learn from and share with.

Host: Karen Plum

Guests:

• Eric Barends, Managing Director, Center for Evidence-Based Management
• Denise Rousseau, H J Heinz University Professor, Carnegie Mellon University
• Jonny Gifford, Senior Researcher, CIPD, the professional body for HR and people development with a worldwide community of 160k members
• David Creelman, CEO of Creelman Research and an expert of HR strategy, analytics and learning
• Stefanie Nickel, Global Head of Diversity & Inclusion, pharmaceutical manufacturer Sandoz, part of the Novartis Group
• Steven ten Have, Partner TEN HAVE Change Management & Professor of Strategy and Change at VU University Amsterdam

Find out more about the course here: https://cebma.org/resources-and-tools/course-modules/

This episode accompanies Module 14 of the course, which is about evaluating the outcome of the decision we’ve taken or the solution we implemented. This is the last stage of our evidence-based management process and is vital to ensuring that we learn from what we’ve done.

Assessing outcomes is vital, because otherwise, how do we know if what we did was effective, and how can we learn and develop our approach to decision making? Did we capture a baseline before the decision was implemented? And was the decision implemented as planned? If we assess outcomes without these two, then conclusions could be very suspect.

We continue our case study of the large trial at pharmaceutical organization Sandoz (part of Novartis Group), and find out how the D&I interventions were assessed.

Denise Rousseau's 2020 paper: Making Evidence based organisational decisions in an uncertain world

After action review paper: https://www.cebma.org/wp-content/uploads/Guide-to-the-after_action_review.pdf

Host: Karen Plum

Guests:

• Eric Barends, Managing Director, Center for Evidence-Based Management
• Denise Rousseau, H J Heinz University Professor, Carnegie Mellon University
• Stefanie Nickel, Global Head of Diversity & Inclusion, pharmaceutical manufacturer Sandoz, part of the Novartis Group

Additional speaker, courtesy of CIPD: Niamh McNamara, Global Head of People & Organisation, Novartis

Find out more about the course here: https://cebma.org/resources-and-tools/course-modules/

This episode accompanies Module 13 of the course, which is about incorporating evidence into the decision making process.

Is the evidence appropriate for our situation (is it generalizable). Can we (and should we) action the evidence? And what are the practical aspects associated with using the evidence that we’ve gathered? The real world is messy and complex, so there are many things to take into consideration.

We share real world examples from professional HR body CIPD, Creelman Research and a large trial at pharmaceutical organization Sandoz (part of Novartis Group), which shows not only the power of capturing stakeholder experiences, but the value of keeping interventions simple and practical.

Host: Karen Plum

Guests:

• Eric Barends, Managing Director, Center for Evidence-Based Management
• Denise Rousseau, H J Heinz University Professor, Carnegie Mellon University
• Jonny Gifford, Senior Researcher, CIPD, the professional body for HR and people development with a worldwide community of 160k members
• David Creelman, CEO of Creelman Research and an expert of HR strategy, analytics and learning
• Stefanie Nickel, Global Head of Diversity & Inclusion, pharmaceutical manufacturer Sandoz, part of the Novartis Group

Find out more about the course here: https://cebma.org/resources-and-tools/course-modules/